Our previous results showed that hPMSCs could alleviate GVHD symptoms by maintaining the balance of CD4+IL-10+ T cells and Th17 subsets [6]; however, the specific mechanism by which hPMSCs regulate the generation of CD4+IL-10+ T cells remains unclear. Here, IL10 is linked to graft versus host disease.